ClinConnect ClinConnect Logo
Search / Trial NCT06198829

Evaluation of the Clinical Parameters and Kinesiophobia in Femoroacetabular Impingement Syndrome

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Dec 28, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Pain Kinesiophobia Weight Bearing Femoracetabular Impingement

ClinConnect Summary

This clinical trial is looking into how fear of movement, known as kinesiophobia, affects people with a condition called Femoroacetabular Impingement Syndrome (FAIS). FAIS can cause hip pain and discomfort, and the researchers want to understand how this fear might relate to patients' symptoms and overall health. By studying this relationship, they hope to improve care for those dealing with FAIS.

If you're between 18 and 65 years old and have been diagnosed with a specific type of FAIS called "cam" type, you might be eligible to participate. It's important that you haven't had any hip surgeries in the past year and that you're willing to fill out some forms to consent to the study. Participants can expect to share information about their health and feelings related to movement, helping researchers gain insights that could benefit others with similar issues. If you have a history of psychological conditions or other illnesses that could confuse the results, you may not be able to join this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 18 and 65
  • Being diagnosed with 'cam' type femoroacetabular impingement syndrome
  • Having no surgical history in the hip area and its vicinity within the last 1 year
  • Having filled out the informed consent form
  • Exclusion Criteria:
  • Having a history of psychological and mental illness
  • Having another illness with symptoms that may overlap with FAI symptoms
  • Refusing to participate in the study

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, Atasehir, Turkey

Patients applied

0 patients applied

Trial Officials

Gulay Aras Bayram, Assist.Prof.

Study Director

Istanbul Medipol University School of Health Science

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported